Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425428
Max Phase: Preclinical
Molecular Formula: C37H44F3N5O8
Molecular Weight: 629.76
Molecule Type: Small molecule
Associated Items:
ID: ALA2425428
Max Phase: Preclinical
Molecular Formula: C37H44F3N5O8
Molecular Weight: 629.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](Cc1ccccc1)C(=O)NCCO.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C35H43N5O6.C2HF3O2/c1-39(31(32(43)37-18-20-41)23-25-11-6-3-7-12-25)35(46)29(22-24-9-4-2-5-10-24)38-33(44)30-13-8-19-40(30)34(45)28(36)21-26-14-16-27(42)17-15-26;3-2(4,5)1(6)7/h2-7,9-12,14-17,28-31,41-42H,8,13,18-23,36H2,1H3,(H,37,43)(H,38,44);(H,6,7)/t28-,29-,30-,31-;/m0./s1
Standard InChI Key: FMXINHXJJBNTPF-IUQRHOJWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.76 | Molecular Weight (Monoisotopic): 629.3213 | AlogP: 1.16 | #Rotatable Bonds: 14 |
Polar Surface Area: 165.30 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 7.72 | CX LogP: 1.56 | CX LogD: 1.20 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.18 | Np Likeness Score: -0.08 |
1. Mollica A, Costante R, Stefanucci A, Pinnen F, Luisi G, Pieretti S, Borsodi A, Bojnik E, Benyhe S.. (2013) Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation., 68 [PMID:23974016] [10.1016/j.ejmech.2013.07.044] |
Source(1):